Effect of Alfacalcidol on Muscle Function in Osteoporosis Patients; Double-blinded Randomized Controlled Trial
This clinical trial, sponsored by Yonsei University, aims to evaluate the efficacy of alfacalcidol in enhancing muscle function in postmenopausal women with osteoporosis and functional sarcopenia. The study will involve 340 participants over a one-year period, comparing outcomes between the alfacalcidol and placebo groups.
Indication: Sarcopenia
Modality: monoclonal antibody
Target: Muscle function improvement in osteoporosis patients
Sponsor: Yonsei University
Source URL: ClinicalTrials.gov
Source updated: Feb 22, 2024
Ingested: May 30, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Muscle function improvement in osteoporosis patients
View original source fields
Condition raw: Sarcopenia
Condition normalized: Sarcopenia
Modality raw: Sarcopenia
Modality normalized: monoclonal antibody
Target raw: Muscle function improvement in osteoporosis patients
Target normalized: Muscle function improvement in osteoporosis patients